China National Medicines Corporation Ltd. Class ASSE: 600511

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by China National Medicines Corporation Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from China National Medicines Corporation Ltd. Class A

All China National Medicines Corporation Ltd. Class A news releases